Use of Indocyanine Green (ICG) for the Diagnosis of Biliary Atresia — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Use of Indocyanine Green (ICG) for the Diagnosis of Biliary Atresia — Stella

Recruiting

Back to Biliary Atresia trials

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(1 site)

United States

Boston Children's Hospital, Boston, Massachusetts

Key details

Phase

Early testing / Safety & dosing

Sponsor

Boston Children's Hospital

Enrollment target

~20 participants

Started

August 2024

Primary completion

August 2026

Age range

0 Days – 3 Months

Last updated April 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov